Arcadia Biosciences (RKDA) Reports Q1 Loss, Tops Revenue Estimates
Yahoo Finance · 2 weeks ago
Open | 3.0924 |
High | 3.1596 |
Low | 2.8900 |
Mkt Cap | 4.23M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 3.1000 |
52 Wk. Low | 1.8510 |
52 Wk. High | 5.6000 |
Related stocks
Company in Davis, United States
Arcadia Biosciences is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 1.25M | 16.80% ▼ |
Net Income | -2.42M | - |
Diluted EPS | -1.78 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$1.55 | - |
Q1 2024 | -$2.21 | -$1.78 |
Q4 2023 | -$2.58 | -$2.52 |
S&P FuturesES=F | 5,339.00-6.25 (-0.12%) |
Dow FuturesYM=F | 39,970.00-36.00 (-0.09%) |
Nasdaq FuturesNQ=F | 18,788.00-11.25 (-0.06%) |
Tesla, Inc.TSLA | 186.60+6.66% |
953.86+0.64% | |
MGO Global, Inc.MGOL | 1.2500+446.57% |